Guidance from Societies:

• COVID-19 CORONAVIRUS UPDATES, TTS COVID-19 Dashboard
• Guidance on Coronavirus Disease 2019 (COVID-19) for Transplant Clinicians from the TID Section of TTS: https://tts.org/tid-about/tid-presidents-message/23-tid/tid-news/657-tid-update-and-guidance-on-2019-novel-coronavirus-2019-ncov-for-transplant-id-clinicians
• Global Transplantation Covid Report March 2020
• Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic. AASLD Expert Panel Consensus Statement. This is a live, regularly updated document.

Surgical Infection Society Guidance:

• Heffernan DS, et al. Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Surgical Infections. April 20, 2020.

COVID-19 and Organ Donation

• OPTN: Summary of Current Evidence and Information– Donor SARS-CoV-2 Testing &Organ Recovery from Donors with a History of COVID-19, September 22, 2021

Articles Regarding COVID-19 Clinical Presentations and Management:

Solid Organ Or Liver Transplant, Liver dysfunction:

• Feng G, et al. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. JCTH. 2020: (8)18–24
• Webb G, et al. Determining risk factors for mortality in liver transplant patients with COVID-19. Lancet Gastro and Hep. April 24, 2020.
• Pereira et al. COVID‐19 in Solid Organ Transplant Recipients: Initial Report from the US Epicenter. American Journal of Transplant. American J of Transplant. April 24, 2020.
• Bhoori S, et al. COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy. Lancet Gastro and Hep. April 9, 2020.
• Boettler T, et al. Care of patients with liver disease during the COVID-19 pandemic:EASL-ESCMID Position Paper. April 2, 2020

• Fei Li, Jie Cai, Nianguo Dong, First Cases of COVID-19 in Heart Transplantation From China, Journal of Heart and Lung Transplantation(2020), doi:https://doi.org/10.1016/j.healun.2020.03.006
• Qin, Juanjuan et al., Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient. Hepatology. March 27, 2020
• D’Antiga, Lorenzo, Coronaviruses and Immunosuppressed Patients. The Facts during the Third Epidemic. Liver Transplantation. March 20, 2020
• Siddiqi HK, Mehra MR. COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal. J Heart Lung Transpl. March, 2020.

Pulmonary:

• American College of Radiology: ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection. March 22, 2020
• Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. Published online March 13, 2020. doi:10.1001/jamainternmed.2020.0994
• Song Fengxiang et.al, Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. Feb 6, 2020

Cardiovascular:

• AlGhatrif M, et al. The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science. JAMA. April 3, 2020
• Giudicessi JR, et al. Urgent Guidance for Navigating and Circumventing the QTc Prolonging and TorsadogenicPotential of Possible Pharmacotherapies for COVID-19. Mayo Clin. Proc. March 25, 2020.
• Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China [published online ahead of print, 2020 Mar 25]. JAMA Cardiol. 2020;10.1001/jamacardio.2020.0950
• Hu H, et al. Coronovirus Fulminant Myocarditis Case Report. Eur Heart J. March 16, 2020

Therapies and Surveillance:

• Sanders JM, et al. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review. JAMA. Published online April 13, 2020
• Nikolich-Zugich J, et al. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. GeroScience. Published online April 10, 2020
• Wang Y, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. April 29, 2020.
• Grein J, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. NEJM. April 10, 2020.
• Gudbjartsson DF, et al. Spread of SARS-CoV-2 in the Icelandic Population. NEJM. April 14, 2020
• Caly L, et al. The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antivir Res. April 3, 2020. (preprint)
• Chen Z, et al. Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. March 31, 2020  
• Gautret P, et al. Hydroxychloroquine and Azithromycin As a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial. Int J Antimicrob Agents. March 20, 2020.
• Shen C, et al. Treatment of 5 Critically Ill Patients with COVID-19 with Convalescent Plasma. JAMA. March 27, 2020
• Chan JYK, et al. Practical Aspects of Otolaryngologic Clinical Services During the 2019 Novel Coronavirus Epidemic. JAMA. March 20, 2020
• Yu J, et al. SARS-CoV-2 Transmission in Patients With Cancer. JAMA. March 25, 2020
• Zhen, L, et al. Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Newborns Born to Mothers With COVID-19 in Wuhan, China. JAMA. March 26, 2020
• Liu Y, Yan L, Wan L, Xiang T, Le A, Liu J, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020 Mar 19 [Epub ahead of print]. https://doi.org/10.1016/S1473-3099(20)30232-2
• Mirco Nacoti et al., At the Epicenter of the Covid-19 Pandemic and Humanitarian Crises in Italy: Changing Perspectives on Preparation and Mitigation, NEJM Catalyst, 21 March 2020
• Schmidt Jennifer M., Seeking Evidence-Based Covid-19 Preparedness: A FEMA Framework for Clinic Management, NEJM Catalyst, 25 March 2020

Health Care Providers:

• Ayanian JZ. Mental Health Needs of Health Care Workers Providing Frontline COVID-19 Care. JAMA. April 1, 2020
• Lai J, et al. Factors Associated with Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA, March 23, 2020
• Perlis RH. Exercising Heart and Head in Managing Coronavirus Disease 2019 in Wuhan. JAMA, March 23, 2020

Critical Care updates:

• Davenport L. Top 10 Must-Dos in ICU in COVID-19 Include Prone Ventilation. Medscape. March 31, 2020.
• Internet Book of Critical Care (IBCC) by the EMCrit Project: https://emcrit.org/ibcc/covid19
• Grasselli G. et al. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy. March 13, 2020
• Alhazzani W, et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). March, 2020.
• Poston JT, et al. Management of Critically Ill Adults With COVID-19. JAMA. March 26, 2020.
• Meng L, et al. Intubation and Ventilation Amid the COVID-19 Outbreak: Wuhan’s Experience. Anesthesiology. March 26, 2020.
• Patients with COVID-19 are alone in the ICU, The New York Times
• Health system plan would deny ICU care, ventilators for some patients, Bridge Magazine
• Zack Budryk FDA to facilitate use of convalescent plasma for COVID-19, The Hill
• Hospitals try ventilator-sharing amid shortage, The New York Times

Decontamination and Disinfection:

• Canelli R, et al. Barrier Enclosure during Endotracheal Intubation. JAMA. April 3, 2020.
• Final Report for the Bioquell Hydrogen Peroxide Vapor (HPV) Decontamination for Reuse of N95 Respirators, a comprehensive pilot-scale study by a contractor of the Food and Drug Administration (FDA): https://www.fda.gov/media/136386/download
• DENNIS J. VISCUSI1, MICHAEL S. BERGMAN2, BENJAMIN C. EIMER2 and RONALD E. SHAFFER. 2009. Evaluation of Five Decontamination Methods for Filtering Facepiece Respirators.  The Annals of Occupational Hygiene.
• Lindsley, W., Martin, S., Thewlis, R., Sarkisian, K., Nwoko, J., Mead, K. and Noti, J., 2015. Effects of Ultraviolet Germicidal Irradiation (UVGI) on N95 Respirator Filtration Performance and Structural Integrity. Journal of Occupational and Environmental Hygiene, 12(8), pp.509-517.
• Lore, MB, Heimbuch, BK, Brown, TL, Wander, JD & Hinrichs, SH. 2012. ‘Effectiveness of three decontamination treatments against influenza virus applied to filtering facepiece respirators‘. Annals of Occupational Hygiene. vol. 56, no. 1, pp. 92-101. https://doi.org/10.1093/annhyg/mer054
• Welch, David & Buonanno, Manuela & Grilj, Veljko & Shuryak, Igor & Crickmore, Connor & Bigelow, Alan & Randers-Pehrson, Gerhard & Johnson, Gary & Brenner, David. 2018. Far-UVC light: A new tool to control the spread of airborne-mediated microbial diseases. Scientific Reports. 8. 10.1038/s41598-018-21058-w.
• Hindson, J. COVID-19: faecal-oral transmission? Nature Review, Gastroenterology and Hepatology. March 25, 2020

Additional Resources:

• World Health Organization: COVID-19 Pandemic
• Center for Disease Control and Prevention: COVID-19
• European Centre for Disease Prevention and Control: COVID-19
• UNOS: Member Information Regarding COVID-19
• The Liverpool Drug Interaction Group, in collaboration with the University Hospital of Basel and Radboud UMC have produced various materials in PDF format to aid the use of experimental agents in the treatment of COVID-19:  http://www.covid19-druginteractions.org/
• Conversation: Namita Seth Mohta & Priya Sampathkumar, Learnings from Mayo Clinic’s Methods for Scaling a Coordinated and Comprehensive Plan for Covid-19, NEJM Catalyst
• Commentary: Thomas H. Lee, Creating the New Normal: The Clinician Response to Covid-19, NEJM Catalyst
• Global MediXchange for Combating COVID-19 (GMCC): COVID-19 Resources
• Testimonies from the frontlines. ILTS and partner organizations EASL, ESOT and ELITA share valuable testimonies from healthcare providers around the world on the consequences of the COVID-19 pandemic on their daily working life. April 20, 2020